Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 26, 2026
CIBR's Path to $120: Weighing the Cybersecurity ETF's +40% Rally

CIBR's Path to $120: Weighing the Cybersecurity ETF's +40% Rally

Key Takeaways

  • Selected price target: $120, a psychological milestone sitting just above the highest analyst-derived forecast for the fund's underlying holdings.
  • Strongest bullish factors: Structurally rising cybersecurity budgets, AI-driven threats expanding the attack surface, and robust earnings from top holdings such as CrowdStrike and Palo Alto Networks.
  • Biggest risks: Heavy concentration in a handful of mega-cap names, elevated growth valuations, and sensitivity to broader technology selloffs.
  • Key levels: Support sits near $96–$100, while resistance looms at the recent high and again at the psychological $110 and $120 thresholds.
  • Key takeaway: Reaching $120 is plausible over a multi-quarter horizon but depends on continued earnings delivery rather than multiple expansion alone.

Understanding the CIBR ETF

The First Trust NASDAQ Cybersecurity ETF (CIBR) has been one of the strongest thematic funds in 2026, rallying more than 40% from its January levels to trade near all-time highs above $100. That momentum raises a natural question: can this cybersecurity ETF keep climbing and reach the $120 mark — roughly 18% above its recent price? CIBR tracks the Nasdaq CTA Cybersecurity Index, a liquidity-weighted benchmark of companies classified as cybersecurity providers. Launched in 2015, it has become the largest dedicated cybersecurity ETF by assets, with roughly $9 billion to $11 billion under management across around 36 to 40 names. Its 0.58% expense ratio provides diversified exposure to a theme that many investors now see as essential enterprise spending.

Holdings That Could Drive Further Gains

Any move toward $120 would depend heavily on the fund's concentrated top holdings. Leading positions include Palo Alto Networks (PANW), Fortinet (FTNT), and CrowdStrike (CRWD), along with broader technology names such as Broadcom (AVGO) and Cisco Systems (CSCO) that carry meaningful cybersecurity exposure. I also checked this using Tickeron’s AI Screener to see how these names compare within the sector. This concentration works both ways. The top holdings have posted solid results, with CrowdStrike reporting revenue growth of more than 20% in its most recent fiscal year and record annual recurring revenue, while Palo Alto Networks continues to expand profitably. Yet because the top ten holdings account for well over half the fund, one disappointing earnings report could affect the entire ETF.

Technical Picture and the Road to $120

From a technical standpoint, CIBR has been forming a series of higher highs and higher lows, indicating an intact uptrend. The fund recently surpassed its prior 52-week high into the low-$100s, converting that former resistance into potential support. The $96–$100 zone remains an important area where buyers have stepped in before. Above current levels, the next hurdles are the psychological $110 mark and then $120. Because $120 sits just beyond the highest analyst-derived forecasts for the underlying components, it would likely need a genuine fundamental catalyst, such as strong earnings across key holdings or renewed growth in cybersecurity spending, rather than momentum alone.

Analyst Views and Market Context

Wall Street remains constructive on the holdings that make up CIBR. Consensus ratings skew heavily toward Buy, with an average 12-month implied price target near $95 and the highest forecast approaching roughly $118. TheStreet Pro raised its CIBR price target to $105 in mid-2026, pointing to accelerating AI-driven cyberattacks and projected global cybersecurity spending exceeding $520 billion by 2031. Those targets indicate that while the easiest gains may already be behind the fund, $120 remains attainable if the secular demand story holds. Gartner has forecast worldwide information security spending to grow roughly 13% in 2026, underscoring that cybersecurity continues to rank as a top IT priority even amid economic uncertainty.

Obstacles That Could Slow Progress

Several factors could stand in the way of a move to $120. The fund trades at elevated valuations relative to the broader market, with its fastest-growing holdings carrying premium multiples that leave little margin for disappointment. An earnings miss from CrowdStrike or Palo Alto Networks could lead to multiple compression across the basket. In addition, because CIBR is dominated by growth-oriented technology names, it remains sensitive to shifts in interest-rate expectations and risk-off moves, even when underlying fundamentals stay intact.

Monitoring Progress With Data Tools

When tracking CIBR’s advance, I sometimes reference Tickeron’s AI Daily Buy/Sell Signals to stay updated on shifting technical and market conditions across the holdings.

Using AI Daily Buy/Sell Signals for Research

For investors following CIBR’s progress toward higher levels, AI Daily Buy/Sell Signals from Tickeron offers an automated way to stay informed. The platform uses artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on market conditions, technical behavior, and AI-driven analysis. Traders can apply these signals to identify opportunities, track positions, and spot trend changes more efficiently, providing a data-driven complement to fundamental research on themes like cybersecurity.

Final Assessment

Reaching $120 represents a realistic but not guaranteed outcome for CIBR. The strongest case rests on durable cybersecurity spending, AI-expanded threats, and steady earnings growth from the largest holdings. The main risks involve valuation sensitivity, portfolio concentration, and the fund’s tendency to move with broader technology sectors. Investors should watch upcoming earnings from top holdings, enterprise IT spending trends, and whether the fund holds above the $96–$100 support zone. A move toward $110 first would suggest $120 is within reach, while a break below support would likely push any test of the target further out.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CIBR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CIBR's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CIBR turned positive on September 15, 2026. Looking at past instances where CIBR's MACD turned positive, the stock continued to rise in 43 of 46 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 14, 2026. You may want to consider a long position or call options on CIBR as a result. In 65 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

CIBR moved above its 50-day moving average on September 11, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where CIBR advanced for three days, in 313 of 363 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 261 of 302 cases where CIBR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CIBR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOGL), Microsoft Corp (NASDAQ:MSFT), Broadcom Inc. (NASDAQ:AVGO), Cisco Systems (NASDAQ:CSCO), Palo Alto Networks Inc (NASDAQ:PANW), Arista Networks Inc (NYSE:ANET), Crowdstrike Holdings Inc (NASDAQ:CRWD), International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Datadog (NASDAQ:DDOG).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq CTA Cybersecurity Index TM (the "index"). The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as "cyber security" companies by CTA. The fund is non-diversified.

Market Cap

The average market capitalization across the First Trust NASDAQ Cybersecurity ETF (CIBR) ETF is 202.71B. The market cap for tickers in the group ranges from 1.24B to 4.19T. GOOGL holds the highest valuation in this group at 4.19T. The lowest valued company is RDWR at 1.24B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust NASDAQ Cybersecurity ETF (CIBR) ETF was 1%. For the same ETF, the average monthly price growth was 8%, and the average quarterly price growth was 66%. DDOG experienced the highest price growth at 17%, while GEN experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the First Trust NASDAQ Cybersecurity ETF (CIBR) ETF was -29%. For the same stocks of the ETF, the average monthly volume growth was 80% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 48
Price Growth Rating: 39
SMR Rating: 57
Profit Risk Rating: 70
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
CIBR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Technology

Category
Technology
Address
First Trust Exchange-Traded Fund II12o East Liberty Drive, Suite 400Wheaton
Phone
630-241-4141
Web
www.ftportfolios.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
CIBR's Path to $120: Weighing the Cybersecurity ETF's +40% Rally